ClinicalTrials.Veeva

Menu

COVID-19 Antibodies Among Healthcare Workers

H

Hospital Universitario Dr. Jose E. Gonzalez

Status

Completed

Conditions

COVID-19
SARS-CoV 2

Treatments

Diagnostic Test: COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA)

Study type

Observational

Funder types

Other

Identifiers

NCT04425889
IF20-00008

Details and patient eligibility

About

Observational, point of prevalence study determining the presence of anti-SARS-CoV-2 antibody

Full description

All Healthcare workers (HCW) who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance to contaminated areas were included. They were classified as asymptomatic and pauci-symptomatic. A COVID-19 IgG/IgM rapid test was used for antibody detection, and selected participants were subject to real time polymerase chain reaction (qPCR) for SARS-CoV-2.

Enrollment

156 patients

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All healthcare workers who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance were included

Exclusion criteria

  • Healthcare workers who did not have exposure for more or equal 14 days
  • Healthcare workers who did not wish to participate

Trial design

156 participants in 1 patient group

exposed Healthcare workers
Description:
Healthcare workers working for 8 weeks in a COVID-19 area
Treatment:
Diagnostic Test: COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems